I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Daghistani, Doured
47
results:
Search for persons
X
Format
Online (47)
Mediatypes
Articles (Online) (20)
OpenAccess-fulltext (27)
Sorted by: Relevance
Sorted by: Year
?
1
Selective DRD2 antagonist and ClpP agonist ONC201 in a recu..:
Odia, Yazmin
;
Hall, Matthew D
;
Cloughesy, Timothy Francis
...
Neuro-Oncology. 26 (2024) Supplement_2 - p. S165-S172 , 2024
Link:
https://doi.org/10.1093/..
?
2
Safety and pharmacokinetics of ONC201 (dordaviprone) admini..:
Odia, Yazmin
;
Koschmann, Carl
;
Vitanza, Nicholas A
...
Neuro-Oncology. 26 (2024) Supplement_2 - p. S155-S164 , 2024
Link:
https://doi.org/10.1093/..
?
3
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midlin..:
Venneti, Sriram
;
Kawakibi, Abed Rahman
;
Ji, Sunjong
...
Cancer Discovery. 13 (2023) 11 - p. 2370-2393 , 2023
Link:
https://doi.org/10.1158/..
?
4
SYST-07 WINDOW-OF-OPPORTUNITY STUDY OF ONC201 IN PEDIATRIC ..:
Odia, Yazmin
;
Koschmann, Carl
;
Tarapore, Rohinton
...
Neuro-Oncology Advances. 4 (2022) Supplement_1 - p. i22-i22 , 2022
Link:
https://doi.org/10.1093/..
?
5
Phase I dose escalation and expansion trial of single agent..:
Gardner, Sharon L
;
Tarapore, Rohinton S
;
Allen, Jeffrey
...
Neuro-Oncology Advances. 4 (2022) 1 - p. , 2022
Link:
https://doi.org/10.1093/..
?
6
CTNI-61. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC..:
Kawakibi, Abed Rahman
;
Tarapore, Rohinton
;
Gardner, Sharon
...
Neuro-Oncology. 24 (2022) Supplement_7 - p. vii86-vii87 , 2022
Link:
https://doi.org/10.1093/..
?
7
CTNI-27. SINGLE AGENT ACTIVITY OF ONC201 IN NON-MIDLINE H3 ..:
Odia, Yazmin
;
Sumrall, Ashley
;
Cloughesy, Timothy
...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi65-vi65 , 2021
Link:
https://doi.org/10.1093/..
?
8
CTNI-36. SAFETY OF ONC201 ADMINISTERED TWO CONSECUTIVE DAYS..:
Gardner, Sharon
;
Koschmann, Carl
;
Tarapore, Rohinton
...
Neuro-Oncology. 23 (2021) Supplement_6 - p. vi67-vi67 , 2021
Link:
https://doi.org/10.1093/..
?
9
CTNI-17. CLINICAL EFFICACY AND PREDICTIVE BIOMARKERS OF ONC..:
Rahman Kawakibi, Abed
;
Tarapore, Rohinton S
;
Gardner, Sharon
...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii45-ii46 , 2020
Link:
https://doi.org/10.1093/..
?
10
DIPG-52. PHASE I CLINICAL TRIAL OF ONC201 IN PEDIATRIC H3 K..:
Gardner, Sharon
;
Tarapore, Rohinton
;
Allen, Jeffrey
...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii297-iii297 , 2020
Link:
https://doi.org/10.1093/..
?
11
CTNI-15. CLINICAL EFFICACY OF ONC201 IN NEWLY DIAGNOSED DIP..:
Gardner, Sharon
;
Koschmann, Carl
;
Tarapore, Rohinton S
...
Neuro-Oncology. 22 (2020) Supplement_2 - p. ii45-ii45 , 2020
Link:
https://doi.org/10.1093/..
?
12
HGG-18. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MUT..:
Kawakibi, Abed Rahman
;
Tarapore, Rohinton S
;
Gardner, Sharon
...
Neuro-Oncology. 22 (2020) Supplement_3 - p. iii347-iii347 , 2020
Link:
https://doi.org/10.1093/..
?
13
PDCT-12. CLINICAL EFFICACY OF ONC201 IN THALAMIC H3 K27M-MU..:
Rahman Kawakibi, Abed
;
Gardner, Sharon
;
Chi, Andrew
...
Neuro-Oncology. 21 (2019) Supplement_6 - p. vi186-vi186 , 2019
Link:
https://doi.org/10.1093/..
?
14
Pediatric and adult H3 K27M-mutant diffuse midline glioma t..:
Chi, Andrew S.
;
Tarapore, Rohinton S.
;
Hall, Matthew D.
...
Journal of Neuro-Oncology. 145 (2019) 1 - p. 97-105 , 2019
Link:
https://doi.org/10.1007/..
?
15
DIPG-42. CAN WE CHANGE THE LANDSCAPE OF PEDIATRIC DIFFUSE I..:
Hall, Matthew
;
Odia, Yazmin
;
Allen, Joshua
...
Neuro-Oncology. 20 (2018) suppl_2 - p. i57-i57 , 2018
Link:
https://doi.org/10.1093/..
1-15